The company will use proceeds from the IPO towards the development of company’s ongoing and upcoming projects.

The company's market valuation reached Rs 3,232.40 crore. Arkade Developers IPO successfully concludes with a massive 106.40 times subscription. The IPO received bids for over 252 crore shares, ...

The peers of BEML Land Assets Ltd are NCC Ltd, Mahindra Lifespace Developers Ltd, Man Infraconstruction Ltd, Arkade Developers ... Ltd. ACME Solar Holdings IPO: Issue subscribed 70% on Day 2 ...

Swiggy's IPO share allotment is expected to be finalized later on Saturday. Shares will be allocated through a lottery system ...

Involves transaction of at least 0.5% of the listed shares of a company. Arkade Developers Ltd share price was down by -0.11% from the previous closing price of ₹142.24. Who are peers of Arkade ...

But, what is emboldening the startups to revisit their IPO plans, a year after many of them shelved or postponed their plans? The answer is the thawing funding winter, a renewed push for ...

PETALING JAYA: Mini-market chain retailer 99 Speed Mart Retail Holdings Bhd has launched its initial public offering (IPO) which will raise RM2.36bil, the country’s largest IPO in seven years.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Prior to the IPO launch, Garuda Construction raised ₹75 crore from institutional investors through its anchor book on October 7. The company has set a price band of Rs 92-95 per share ...

Nifty is trading at a 12-month forward P/E of 20.7x, in line with its long-period average (LPA) of 20.5x. Among banks, PSUs ...

Afcons Infrastructure IPO listing date is today, November 4, 2024. Stock market analysts and the trends in Afcons Infrastructure IPO GMP ahead of share listing indicate a flat debut of shares today.

According to a prospectus on the IPO, Zenas ended the second quarter with around $184 million in cash and has earmarked most of the IPO proceeds for obexelimab's clinical trials programme ...